Skip to main content
. Author manuscript; available in PMC: 2011 Jun 30.
Published in final edited form as: Mol Ther. 2008 Aug 19;16(10):1761–1769. doi: 10.1038/mt.2008.172

Table 3.

Summary of nuclear imaging results

Prostate
Extra-prostatic
Cohort Patient Imaging day GE detecteda GEVb (cm3) % Total GEV:backgroundc Total GEd GE detected
1 1 4 N ND ND ND N
2 4 N ND ND ND N
3 4 N ND ND ND N
2 4 4 Y 7.8 17.3 3.3 25.8 N
5 4 N ND ND ND N
6 4 Y 6.6 26.7 1.5 9.8 N
7 4 N ND ND ND N
8 2 Y 6.8 19.8 2.1 14.3 N
9 2 Y 8.3 18.1 1.9 15.8 N
10 2, 3, 4, 8 Y, Y, Y, Y 7.0 22.6 3.8 26.6 N
11 2, 3, 4 Y, Y, N 1.4 4.3 1.7 2.4 N
12 2, 3, 4, 8 Y, Y, Y, N 8.1 15.4 1.8 14.9 N
Mean 6.6 17.7 2.3 15.7
a

Gene expression (GE) detected by nuclear imaging. Y, yes; N, no.

b

Gene expression volume (GEV) detected in the prostate at maximum. The % total is the GEV divided by the total prostate volume as determined by transrectal ultrasound.

c

Ratio of mean pixel intensity in region of interest (ROI) containing gene expression to mean pixel intensity of ROI in the uninjected prostate (background).

d

Total GE is the GEV multiplied by the GEV:background ratio. The units are arbitrary.